NCI restructures government-supported cancer trials programme in US
This article was originally published in Scrip
Executive Summary
The US National Cancer Institute has announced major changes to the government-supported Cancer Trials Cooperative Group Program that conducts many of the trials of new cancer therapies. As part of the overhaul, the NCI – part of the National Institutes of Health – intends to consolidate the nine groups that currently conduct trials in adult cancer patients into four state-of-the art entities that will design and perform improved trials of cancer therapies.